09.04.2021 • News

Oqema Takes Spain’s Proquibasa

Oqema, a Germany-based distributor of commodity and specialty chemicals, has acquired Spain’s Proquibasa. Financial terms of the transaction were not disclosed.

The Barcelona-based family company focuses on the coatings, construction, adhesives, industrial cleaning, textile and water treatment, food, feed and pharma sectors. Active in the Spanish market for more than 40 years, it has recently expanded to Portugal and North Africa.

Proquibasa has two main warehouses in Barcelona and Madrid, as well as a network of warehouse locations across both Spain and Portugal.

Oqema’s CEO Peter Overlack said he is “looking forward to expanding and developing the business on the Iberian Peninsula”, which until now has been a geographical gap in the German distributor’s portfolio.

The takeover follows two other acquisitions so far this year. Oqema bought a majority share in Austria’s CB Chemie and acquired Hamburg, Germany-based Claus Nitsche & Sohn, which specializes in high-quality essential oils, natural flavors and fragrance ingredients.

Author: Elaine Burridge, Freelance Journalist

Oqema, a Germany-based distributor of commodity and specialty chemicals, has...
Oqema, a Germany-based distributor of commodity and specialty chemicals, has acquired Spain’s Proquibasa. The Barcelona-based family company focuses on the coatings, construction, adhesives, industrial cleaning, textile and water treatment, food, feed and pharma sectors. (c) Proquibasa

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read